Asbestos fibres inhibit the in vitro activity of lymphokine-activated killer (LAK) cells from healthy individuals and patients with malignant mesothelioma
- PMID: 1846329
- PMCID: PMC1535470
- DOI: 10.1111/j.1365-2249.1991.tb05593.x
Asbestos fibres inhibit the in vitro activity of lymphokine-activated killer (LAK) cells from healthy individuals and patients with malignant mesothelioma
Abstract
Asbestos exposure is associated with an increased incidence of several malignancies, including malignant mesothelioma (MM). This study evaluates the relationship between asbestos exposure and the in vitro generation and function of LAK cells, an immune effector cell population with powerful lytic activity against MM cells. Both serpentine (chrysotile) and amphibole (amosite and crocidolite) forms of asbestos fibres suppress LAK cell generation, viability (by 5-11%, P less than 0.02) and cell recovery (by 13-15%, P less than 0.02). However, the LAK cells generated in the presence of the amphiboles were as effective as unexposed cells in lysing both standard tumour cell targets (K562, 56.4% lysis versus 61.5%, respectively, P greater than 0.5; NS; Daudi, 60.5% lysis versus 64.5% P greater than 0.5; NS), and MM tumour cell targets (mean of three MM cell lines 48.3% versus 46.3%, P greater than 0.5; NS), whereas the function of LAK cells generated in the presence of chrysotile was significantly reduced against three out of the five tumour cell targets tested (P less than 0.03). In the presence of asbestos fibres, LAK cell function was reduced against all five tumour cell targets (P less than 0.01), irrespective of whether the cell donors were healthy individuals or patients with MM. NK cell activity was also suppressed (P less than 0.01). The serpentine form of asbestos, chrysotile, was significantly more suppressive of both effector cell functions than either of the amphiboles (P less than 0.01). These findings suggest that asbestos exposure may suppress the function and in some instances the generation of immune effector cell mechanisms, thereby increasing the risk of disease and malignancy.
Similar articles
-
Indomethacin augments lymphokine-activated killer cell generation by patients with malignant mesothelioma.Clin Immunol Immunopathol. 1989 Oct;53(1):68-77. doi: 10.1016/0090-1229(89)90102-5. Clin Immunol Immunopathol. 1989. PMID: 2788546
-
Lysis of human malignant mesothelioma cells by natural killer (NK) and lymphokine-activated killer (LAK) cells.Am Rev Respir Dis. 1989 Jun;139(6):1369-74. doi: 10.1164/ajrccm/139.6.1369. Am Rev Respir Dis. 1989. PMID: 2786360
-
Capacity of tumor necrosis factor to augment lymphocyte-mediated tumor cell lysis of malignant mesothelioma.Clin Immunol Immunopathol. 1991 Jan;58(1):80-91. doi: 10.1016/0090-1229(91)90150-9. Clin Immunol Immunopathol. 1991. PMID: 1983971
-
Deposition and retention of inhaled fibres: effects on incidence of lung cancer and mesothelioma.Occup Environ Med. 1994 Dec;51(12):793-8. doi: 10.1136/oem.51.12.793. Occup Environ Med. 1994. PMID: 7849861 Free PMC article. Review.
-
Airborne fibre concentrations and lung burden compared to the tumour response in rats and humans exposed to asbestos.Ann Occup Hyg. 1995 Oct;39(5):715-25. Ann Occup Hyg. 1995. PMID: 8526402 Review.
Cited by
-
Successful immunochemotherapy for patients with malignant mesothelioma: report of two cases.Surg Today. 1998;28(6):647-51. doi: 10.1007/s005950050200. Surg Today. 1998. PMID: 9681617
-
Current therapy for malignant mesothelioma.Curr Oncol Rep. 2002 Jul;4(4):305-13. doi: 10.1007/s11912-002-0006-2. Curr Oncol Rep. 2002. PMID: 12044240 Review.
-
Nonpulmonary outcomes of asbestos exposure.J Toxicol Environ Health B Crit Rev. 2011;14(1-4):122-52. doi: 10.1080/10937404.2011.556048. J Toxicol Environ Health B Crit Rev. 2011. PMID: 21534087 Free PMC article. Review.
-
One-year follow-up of the phagocytic activity of leukocytes after exposure of rats to asbestos and basalt fibers.Environ Health Perspect. 1994 Oct;102 Suppl 5(Suppl 5):201-3. doi: 10.1289/ehp.102-1567276. Environ Health Perspect. 1994. PMID: 7882931 Free PMC article.
-
Expression of cancer-associated molecules in malignant mesothelioma.Biomark Insights. 2007 May 30;2:173-84. Biomark Insights. 2007. PMID: 19662202 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous